Over the past two decades, continued improvements in the understanding of HIV, chronic viral hepatitis and haematological oncology have led to the development of significant new treatments, with multiple therapeutic options now available in these disease areas. As a result, many patients are living longer and have an improved quality of life.
However, while much research at a basic science and clinical trial level is focused on drug discovery and evaluation, Gilead recognises that a key part of improving patient care in real terms is the development of approaches to diagnosis, treatment and education at a local practice level. Learnings from successful initiatives can be applied to other communities and/or replicated in other parts of the country, to provide practical solutions to current challenges across HIV, chronic viral hepatitis and haematological oncology.
The aim of the Gilead Australia Fellowship: Research Grants Program is to support the development, exploration and implementation of best practice in enhancing patient care in the specific disease areas of HIV, chronic viral hepatitis and haematological oncology.
Gilead Sciences Pty Ltd is proud to work in partnership with the Australian research and clinical community to provide opportunities for ongoing scientific investigation and research.
Gilead is committed to supporting innovative local research initiatives that ultimately improve patient care. As part of this commitment, the Gilead Australia Fellowship has established the Research Grants Program, enabling Australian researchers in HIV, chronic viral hepatitis and haematological oncology to apply for funding support for projects with a clinical and 'real-world' focus.
Gilead Australia is committed to supporting HIV, chronic viral hepatitis and haematological oncology clinical research projects through the Research Grants Program
Researchers in Australia currently face increasing competition for limited funding, particularly for projects with a local or community focus. In recognition of the impact such projects can have on patient care, and following a highly successful funding framework used in the UK and Europe, the Gilead Australia Fellowship: Research Grants Program aims to help bridge a gap in local Australian research funding.
The Research Grants Program will provide grants to support novel clinical research projects across Australia that can inform and shape best practice in patient care across the disease areas of HIV, chronic viral hepatitis and haematological oncology.
Applications that are successful in receiving funding from the Research Grants Program will be those ultimately focused on investigating solutions to improve care for patients with HIV and/or chronic viral hepatitis, and haematological malignancies. Projects may be based on sociological and epidemiological aspects of patient care in these three therapy areas, as well as practical aspects. A key focus for the judges is innovation, with projects driven by novel approaches particularly sought.
Research proposals are invited that explore and address the following issues and themes:
The Research Grants Program provides funding for clinical and academic staff at Australian hospitals, clinics, universities and research institutes, young investigators, nurses, GPs and other healthcare providers/researchers from professional organisations, in both urban and rural areas. Applications for community based projects that may not necessarily fall under traditional research grant criteria are welcome. The decision to fund a project will be made by an independent panel and is entirely unrelated to the use of any particular therapeutic agent.
For the 2018 Research Grants Program, the total funding available is $250,000. It is anticipated that at least one project will be funded in each of the three therapeutic areas, subject to project proposals meeting the judging criteria. The requested level of funding should be stated at the time of application, although the exact amount of funding allocated to each project may vary depending on the nature of the project. Funding is contingent on ethics approval being granted (if required), and all projects must be completed by the end of 2018.
The applications will be reviewed by a judging panel made up of experts from across Australia recognised for their contributions to research in HIV, chronic viral hepatitis and haematological oncology, as well as senior Australian public figures. In addition to the Panel, a member of Gilead senior management will be present at the judging sessions.
All applications and supporting documents must be submitted using the online form on the Gilead Australia Fellowship website (www.gileadfellowship.com.au). Please see the Guidance for applicants page for more information.
All applications will be reviewed by the judging panel against clear criteria established to ensure balance and relevance (please see the Guidance for applicants page for more information). Each application should demonstrate the following:
The website will open for applications on 10 April 2017 and close on 1 September 2017. Please see the Guidance for applicants page for more information.
If you have any questions regarding the Research Grants Program, please contact firstname.lastname@example.org.
For more specific application queries, or if you would like to speak with someone in person to discuss your application, please contact the Medical Department at Gilead on 61 3 9272 4400.
Please note that all queries must be directed as above and applicants may not contact the judges individually.